Avid Bioservices Inc expected to post breakeven results a share - Earnings Preview

Avid Bioservices

02/12/2022 21:03

* Avid Bioservices Inc  CDMO.OQ   CDMO.O  is expected
to show a
rise in quarterly revenue when it reports  results on December
6. 
    * The Tustin California-based  company is expected to report
 a
22.8% increase in revenue to $32.049 million from $26.11 million
a year ago, according to the mean estimate from 4 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Avid Bioservices
Inc is
for breakeven results per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Avid
Bioservices
Inc is $26​, above​ its last closing price of $15.78. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jul. 31 2022  0.04        0.04       0.02      Missed  -45.5
 Apr. 30 2022  0.01        0.01       0.01      Met     0
 Jan. 31 2022  0.05        0.04       0.04      Met     0​
 Oct. 31 2021  0.03        0.03       0.06      Beat    140
 ​​Jul.        0.04        0.04       0.10      Beat    166.7
 31 2021                                                
 Apr. 30 2021  0.00        0.01       -0.04     Missed  -900​
 Jan. 31 2021  -0.03       -0.03      0.01      Beat    133.3
 Oct. 31 2020  -0.05       -0.06      0.01      Beat    117.6
 This summary was machine generated December 2 at 21:03 GMT.  All
figures in US dollars  unless otherwise stated